期刊文献+

经鼻给予布托啡诺对开颅手术麻醉呼气末异氟醚浓度的影响 被引量:1

The effect of intranasal Butorphanol on the end-tidal pressure of Isoflurane in craniotomy
下载PDF
导出
摘要 目的:研究麻醉前应用酒石酸布托啡诺鼻喷剂对开颅手术患者术中呼气末异氟醚浓度(PETIso)的影响。方法:采用随机、双盲、对照研究,选择我院择期行开颅手术的患者60例,将其分为布托啡诺组(B组)和生理盐水组(S组),每组30例。B组给予酒石酸布托啡诺2喷(2 mg),S组给予生理盐水2喷。麻醉前15 min给药。术中调节异氟醚浓度,维持平均动脉压(MAP)在基础值的(+10%)~(-20%)范围内。记录手术各个时间点的血压、心率、PETIso及脑电双频指数(BIS)。结果:B组在切皮、钻骨、开骨瓣后的PETIso显著低于S组(P<0.01);B组在剪硬膜、颅内操作开始、颅内操作10、20、30 min和缝硬膜的PETIso低于S组(P<0.05)。结论:麻醉前15 min经鼻给予酒石酸布托啡诺2 mg能有效减少神经外科手术患者开颅期和颅内操作期的PETIso。 Objective: To observe the effect of intranasal Butorphanol on the end-tidal pressure of Isoflurane(PETIso) and the recovery profiles in craniotomy patients.Methods: A randomized,double-blind,parallel study was used.60 patients of our hospital who was undergoing selective craniotomy in this study were selected and divided into Butorphanol group(group B) and normal saline group(group S),group B was given Butorphanol Tartrate Spray in nasal with 2 puffs(2 mg);Group S was given normal saline with 2 puffs.The medicine was given 15 minutes before anesthesia induction.The concentration of Isoflurane was adjusted to maintain the mean arterial pressure(MAP) within(+10%)-(-20%) of baseline and was recorded at each point of operation.The blood pressure,PETIso and BIS were observed.Results: In group B,the PETIso after the points of skin incision,skull drilling,and skull opening were significantly less than that in group S(P〈0.01);The PETIso in group B at the points of dura incision,intracranial procedure beginning,intracranial 10,20,30 min and suture dura were lower than that in group S(P〈0.05).Conclusion: The application of Butorphanol Tartrate in nasal with 2 mg about 15 min before anesthesia can effectively decrease the PETIso of neurosurgical patients during skull opening and intracranial procedure.
出处 《中国医药导报》 CAS 2011年第28期80-82,共3页 China Medical Herald
关键词 布托啡诺 镇痛 麻醉 开颅术 经鼻给药 Butorphanol Analgesia Anesthesia Craniotomy Intranasal
  • 相关文献

参考文献5

二级参考文献71

  • 1王德明,孙晓峰,张元信,孙永兴,何旭.布托啡诺超前镇痛对罗哌卡因臂丛阻滞效果影响的临床评价[J].中国现代医学杂志,2006,16(21):3281-3283. 被引量:13
  • 2王红珠,王惠琴.不同浓度舒芬太尼用于术后静脉自控镇痛的比较[J].临床医学,2007,27(1):28-29. 被引量:22
  • 3尚书军,朱于临.布托啡诺复合氟哌利多用于术中镇痛镇静的临床观察[J].临床麻醉学杂志,2007,23(4):286-287. 被引量:31
  • 4Commiskey S, Fan LW, Ho IK, et al. Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors []].J Pharmacol Sci, 2005, 98(2): 109-116.
  • 5Vachharajani NN, Shyu WC, Nichola PS, et al. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration[J]. Cephalalgia, 2002, 22(4): 282-287.
  • 6Sela RA, Bruera E, Cormer-spady B, et al. Sensory and affective dimensions of advanced cancer pain[J]. Psychooncology, 2002, 11 (1) :23-34.
  • 7Matsuo N. Characteristics of and strategy for cancer pain[J]. Nippon Rinsho, 2007, 65(1): 17-21.
  • 8Abboud TK, Zhu J, GangollyJ, et al. Transnasal butorphanol: a new method for pain relief in post-cesarean section pain[J]. Acta Anaesthesiol Scand, 1991, 35(1): 14-18.
  • 9Gillis JC, Benfield P, Goa KL. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management. Drugs 1995; 50:157-175.
  • 10Vandam LD. Drug therapy: butorphanol. N Engl J Med 1980; 302:381-384.

共引文献68

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部